AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,000 | +1200.0% | 1,400 | +1929.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 69 | -36.1% | 0.00% | – |
| Q1 2021 | $1,000 | -98.8% | 108 | -98.2% | 0.00% | -100.0% |
| Q3 2020 | $83,000 | -58.9% | 5,839 | -56.7% | 0.01% | -61.5% |
| Q2 2020 | $202,000 | +1088.2% | 13,485 | +625.8% | 0.01% | +1200.0% |
| Q1 2020 | $17,000 | -76.7% | 1,858 | -68.3% | 0.00% | -80.0% |
| Q2 2019 | $73,000 | +1725.0% | 5,852 | +2059.4% | 0.01% | – |
| Q3 2017 | $4,000 | -55.6% | 271 | -79.4% | 0.00% | -100.0% |
| Q1 2017 | $9,000 | -62.5% | 1,313 | -73.0% | 0.00% | -50.0% |
| Q4 2016 | $24,000 | -41.5% | 4,866 | -12.2% | 0.00% | -33.3% |
| Q3 2016 | $41,000 | – | 5,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |